Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion type Assertion NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_head.
- NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion description "[Multivariate Cox analysis showed that only the nuclear expression of YB-1 (p = 0.0136) and high American Joint Committee on Cancer (AJCC) stage (ie stage III or IV) (p < 0.0001) were independent factors for poor prognosis, while the expression of the YB-1 responsive gene products examined was not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_provenance.
- NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion evidence source_evidence_literature NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_provenance.
- NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion SIO_000772 12533839 NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_provenance.
- NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion wasDerivedFrom befree-20140225 NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_provenance.
- NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_assertion wasGeneratedBy ECO_0000203 NP204815.RAndu3TPchmg6wrHB2IGVSvkdJTLVk0KMO6vc4I4UZvcg130_provenance.